Ultrahuman unveiled M2 Live, a continuous glucose monitor that integrates Abbott's Lingo biosensor to track metabolic health through glucose patterns. The system streams data directly to the Ultrahuman app, combining glucose readings with sleep, stress, activity, and recovery metrics to help users understand how their bodies process food and regulate energy throughout the day.

M2 Live positions itself as one of the most affordable wearable metabolic health platforms in the US market. Individual Lingo sensors retail for $129 each, while the monthly subscription costs $99 without requiring a prescription. Sensors can be worn for up to 14 days, and the platform leverages five years of research plus partnerships with health institutions and millions of logged meals to inform its insights.

The system's AI assistant Jade analyzes glucose patterns alongside heart rate variability and sleep data from Ultrahuman's smart ring. Users receive a metabolic score ranging from 0-100, plus Food and Fueling scores that reveal how specific foods and workouts affect their glucose levels. This gives people with diabetes or metabolic concerns concrete feedback rather than just numbers.

M2 Live launches in the US within weeks exclusively through ultrahuman.com. By removing prescription barriers and bundling comprehensive biomarker analysis, Ultrahuman is making metabolic health monitoring more accessible to consumers who previously needed clinical oversight for continuous glucose tracking.